Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012

INTRODUCTION: Fosfomycin is a broad-spectrum cell wall active agent that inhibits the MurA enzyme involved in peptidoglycan synthesis and is FDA-approved for treatment of uncomplicated urinary tract infections (UTIs) caused by Escherichia coli and Enterococcus faecalis in women. Data regarding the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Keepers, Tiffany R., Gomez, Marcela, Celeri, Chris, Krause, Kevin M., Biek, Donald, Critchley, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446363/
https://www.ncbi.nlm.nih.gov/pubmed/28285420
http://dx.doi.org/10.1007/s40121-017-0150-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446363/
https://www.ncbi.nlm.nih.gov/pubmed/28285420
http://dx.doi.org/10.1007/s40121-017-0150-5

Ejemplares similares